POGGESI, ANNA
 Distribuzione geografica
Continente #
NA - Nord America 7.962
EU - Europa 5.049
AS - Asia 3.701
SA - Sud America 496
Continente sconosciuto - Info sul continente non disponibili 148
AF - Africa 110
OC - Oceania 54
Totale 17.520
Nazione #
US - Stati Uniti d'America 7.799
RU - Federazione Russa 1.754
IT - Italia 1.226
SG - Singapore 1.059
CN - Cina 912
HK - Hong Kong 567
PL - Polonia 552
BR - Brasile 406
IE - Irlanda 382
VN - Vietnam 367
SE - Svezia 338
KR - Corea 294
DE - Germania 176
FR - Francia 165
FI - Finlandia 146
IN - India 124
GB - Regno Unito 108
CA - Canada 102
BD - Bangladesh 76
UA - Ucraina 63
JO - Giordania 60
TR - Turchia 57
AU - Australia 52
JP - Giappone 36
NL - Olanda 34
AR - Argentina 32
ID - Indonesia 30
ES - Italia 27
CI - Costa d'Avorio 26
MX - Messico 23
EC - Ecuador 18
ZA - Sudafrica 18
BE - Belgio 17
MA - Marocco 15
NG - Nigeria 14
IQ - Iraq 13
CO - Colombia 12
PH - Filippine 12
UZ - Uzbekistan 12
AE - Emirati Arabi Uniti 11
PK - Pakistan 11
TN - Tunisia 11
MY - Malesia 10
CR - Costa Rica 9
LT - Lituania 9
CL - Cile 8
CZ - Repubblica Ceca 8
HN - Honduras 8
JM - Giamaica 7
EG - Egitto 6
GR - Grecia 6
PY - Paraguay 6
SA - Arabia Saudita 6
VE - Venezuela 6
KZ - Kazakistan 5
MK - Macedonia 5
AL - Albania 4
AZ - Azerbaigian 4
GT - Guatemala 4
KE - Kenya 4
KG - Kirghizistan 4
LB - Libano 4
NI - Nicaragua 4
RO - Romania 4
SN - Senegal 4
TW - Taiwan 4
BO - Bolivia 3
DZ - Algeria 3
ET - Etiopia 3
NP - Nepal 3
OM - Oman 3
PS - Palestinian Territory 3
TH - Thailandia 3
UY - Uruguay 3
BB - Barbados 2
BG - Bulgaria 2
BY - Bielorussia 2
CH - Svizzera 2
EE - Estonia 2
EU - Europa 2
HR - Croazia 2
HU - Ungheria 2
LV - Lettonia 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
PE - Perù 2
PT - Portogallo 2
RS - Serbia 2
SC - Seychelles 2
SY - Repubblica araba siriana 2
AM - Armenia 1
AO - Angola 1
AT - Austria 1
BH - Bahrain 1
BJ - Benin 1
BS - Bahamas 1
CM - Camerun 1
DK - Danimarca 1
IL - Israele 1
IR - Iran 1
Totale 17.362
Città #
Santa Clara 1.277
Ashburn 954
Singapore 712
Fairfield 704
Warsaw 549
Hong Kong 489
Dublin 381
Woodbridge 342
Chandler 319
San Jose 318
Seoul 292
Houston 275
Seattle 275
Cambridge 272
Wilmington 225
Beijing 213
Milan 194
Hefei 163
Council Bluffs 153
Ann Arbor 136
Los Angeles 132
Altamura 131
Lawrence 130
Florence 127
Ho Chi Minh City 122
Buffalo 116
Princeton 111
Jacksonville 107
Lauterbourg 91
Rome 89
Moscow 85
Mumbai 85
The Dalles 83
Hanoi 74
Boston 66
New York 64
Medford 59
Phoenix 52
Melbourne 51
Munich 51
Paris 49
Boardman 48
Shanghai 47
Kent 42
Helsinki 39
San Diego 38
Dallas 37
Izmir 36
São Paulo 35
Tokyo 34
Toronto 28
Abidjan 26
Naples 26
Orem 26
Turku 25
London 24
Turin 23
Frankfurt am Main 22
Falls Church 21
Bologna 20
Chicago 20
Clifton 20
Jakarta 20
Montreal 20
Hillsboro 18
Da Nang 16
Redondo Beach 16
Rio de Janeiro 16
Denver 15
Brussels 14
Guangzhou 14
Haiphong 14
Norwalk 14
Figino 13
Johannesburg 13
Abuja 12
Bari 12
Brooklyn 12
Catania 12
Dong Ket 12
Tianjin 12
Amsterdam 11
Andover 11
Barcelona 11
Belo Horizonte 11
Chennai 11
Palermo 11
Yubileyny 11
Padua 10
Brasília 9
Dearborn 9
Forlì 9
Manchester 9
Tashkent 9
Venice 9
Atlanta 8
Goiânia 8
Pescara 8
San Francisco 8
San José 8
Totale 11.211
Nome #
White matter microstructural damage in small vessel disease is associated with montreal cognitive assessment but not with mini mental state examination performances: vascular mild cognitive impairment tuscany study. 368
Prediction of impaired performance in Trail Making Test in MCI patients with small vessel disease using DTI data 311
Operationalizing mild cognitive impairment criteria in small vessel disease: The VMCI-Tuscany Study 256
Reperfusion Injury after ischemic Stroke Study (RISKS): Single-centre (Florence, Italy), prospective observational protocol study 252
Multimodal MRI classification in vascular mild cognitive impairment 243
Role of biological markers for cerebral bleeding risk STRATification in patients with atrial fibrillation on oral anticoagulants for primary or secondary prevention of ischemic stroke (Strat-AF study): Study design and methodology 239
Incidenza di ictus e leucoaraiosi quali fattori predittivi indipendenti di transizione verso la disabilità: lo studio europeo LADIS (Leukoaraiosis And DISability) 230
Cerebral small vessel disease and systemic arteriopathy in intracranial arterial dolichoectasia patients 227
Cerebral microbleeds in patients with mild cognitive impairment and small vessel disease: The Vascular Mild Cognitive Impairment (VMCI)-Tuscany study 225
Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort 216
Can CHA2DS2-VASc and HAS-BLED Foresee the Presence of Cerebral Microbleeds, Lacunar and Non-Lacunar Infarcts in Elderly Patients With Atrial Fibrillation? Data From Strat-AF Study 209
Circulating Biomarkers in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy Patients 209
Diffusion Tensor Imaging to Map Brain Microstructural Changes in CADASIL 208
Risk and Determinants of Dementia in Patients with Mild Cognitive Impairment and Brain Subcortical Vascular Changes: A Study of Clinical, Neuroimaging, and Biological Markers-The VMCI-Tuscany Study: Rationale, Design, and Methodology. 203
Fractal dimension of cerebral white matter: A consistent feature for prediction of the cognitive performance in patients with small vessel disease and mild cognitive impairment 199
Gender differences in post-stroke functional outcome at discharge from an intensive rehabilitation hospital 198
The serum metabolomic profiles of atrial fibrillation patients treated with direct oral anticoagulants or vitamin K antagonists 194
Trunk Control Test as a Main Predictor of the Modified Barthel Index Score at Discharge From Intensive Post-acute Stroke Rehabilitation: Results From a Multicenter Italian Study 191
The burden of microstructural damage modulates cortical activation in elderly subjects with MCI and leuko-araiosis. A DTI and fMRI study 190
Longitudinal changes in MoCA performances in patients with mild cognitive impairment and small vessel disease. Results from the VMCI-Tuscany Study 189
Mild cognitive impairment etiologic subtyping using pragmatic and conventional criteria: preliminary experience in the Florence VAS-COG clinic. 188
Intravenous thrombolysis in CADASIL: report of two cases and a systematic review 184
Development and Psychometric Properties of a Neuropsychological Battery for Mild Cognitive Impairment with Small Vessel Disease: The VMCI-Tuscany Study. 182
A pathogenic mutation on exon 21 of the NOTCH3 gene causing CADASIL in an octogenarian paucisymptomatic patient 182
White matter microstructural damage and depressive symptoms in patients with mild cognitive impairment and cerebral small vessel disease: the VMCI-Tuscany Study. 182
Age-related white matter changes predict hidden global functioning impairment. 181
Association Between Motor and Cognitive Performances in Elderly With Atrial Fibrillation: Strat-AF Study 181
2001-2011: A Decade of the LADIS (Leukoaraiosis And DISability) Study: What Have We Learned about White Matter Changes and Small-Vessel Disease? 180
Effect of Attention Training in Mild Cognitive Impairment Patients with Subcortical Vascular Changes: The RehAtt Study 176
Facial Affect Recognition in CADASIL Patients. 175
Alterazioni diffuse della sostanza bianca cerebrale ed aumento del rischio di disabilità nei soggetti anziani. Studio Europeo LADIS (Leukoaraiosis And DISability): evidenze dal primo anno di follow-up. 175
The Florence VAS-COG clinic: a model for the care of patients with cognitive and behavioral disturbances consequent to cerebrovascular diseases. 175
Blood–brain barrier leakage and hemorrhagic transformation: The Reperfusion Injury in Ischemic StroKe (RISK) study 174
A pathogenic mutation on exon 21 of the NOTCH3 gene causing CADASIL in an octogenarian paucisymptomatic patient 172
Thrombolysis in acute stroke patients with cerebral small vessel disease 172
Cognitive phenotypes and factors associated with cognitive decline in a cohort of older patients with atrial fibrillation: The Strat-AF study 170
Assessing mental flexibility: neuroanatomical and neuropsychological correlates of the Trail Making Test in elderly people. 170
Impact of cerebral white matter changes on functionality in older adults: An overview of the LADIS Study results and future directions 170
Atrial Fibrillation and Cognition: Epidemiological Data and Possible Mechanisms 168
Comparison between Ischemic and Hemorrhagic Strokes in Functional Outcome at Discharge from an Intensive Rehabilitation Hospital 167
Application of the DSM-5 Criteria for Major Neurocognitive Disorder to Vascular MCI Patients 166
Association of gait and balance disorders with age-related white matter changes: the LADIS study 166
Stroke unit care in clinical practice: an observational study in the Florence center of the European Registers of Stroke (EROS) Project. 166
Influence of vascular risk factors and neuropsychological profile on functional performances in CADASIL: results from the MIcrovascular LEukoencephalopathy Study (MILES). 166
Coronary microvascular function is impaired in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy 166
Resting state fMRI regional homogeneity correlates with cognition measures in subcortical vascular cognitive impairment 163
Confirmatory factor analysis of the Neuropsychological Assessment Battery of the LADIS study: a longitudinal analysis. 163
Age-related white matter changes and heart failure. The LADIS (Leukoaraiosis And DISability) Study. 160
Age-related white matter changes as independent predictors of disability in the elderly. The LADIS (Leukoaraiosis and disability) Project: evidence from the first year follow-up. 159
Familial cerebral cavernous malformation: report of a further Italian family 158
Physical activity in the elderly is associated with improved executive function and processing speed: The LADIS Study 154
Leukoaraiosis as an outcome predictor in the acute and subacute phases of stroke 153
The role of extracellular matrix and inflammation in the stratification of bleeding and thrombotic risk of atrial fibrillation on oral anticoagulant therapy: insights from Strat-Af study 153
Predictors of Function, Activity, and Participation of Stroke Patients Undergoing Intensive Rehabilitation: A Multicenter Prospective Observational Study Protocol 153
Association of nimodipine and choline alphoscerate in the treatment of cognitive impairment in patients with cerebral small vessel disease: study protocol for a randomized placebo-controlled trial—the CONIVaD trial 153
Major depression and bipolar disorders in CADASIL: a study using the DSM-IV semi-structured interview 149
Physical Activity Prevents Progression for Cognitive Impairment and Vascular Dementia: Results From the LADIS (Leukoaraiosis and Disability) Study. 149
The rehabilitation of attention in patients with mild cognitive impairment and brain subcortical vascular changes using the Attention Process Training-II. The RehAtt Study: rationale, design and methodology 149
Relevance of brain lesion location for cognition in vascular mild cognitive impairment 148
Assessment of cerebrovascular disease with computed tomography in COVID-19 patients: correlation of a novel specific visual score with increased mortality risk 144
Cardiac calcified amorphous tumor as a rare cause of ischemic stroke: Clinical case 143
Cortical activation correlates of leuko-araiosis. A fMRI and DTI study 143
Calcium channel blockers and stroke prevention 141
CALCIUM CHANNEL BLOCKERS AND STROKE. 140
Cognitive decline and dementia related to cerebrovascular diseases: some evidence and concepts 140
Critical issue on the extinction and inattention subtest of NIHSS scale: an analysis on post-acute stroke patients attending inpatient rehabilitation 139
Detection of subclinical atrial fibrillation after cryptogenic stroke using implantable cardiac monitors 139
Diffusion changes predict cognitive and functional outcome: the LADIS study. 138
Efficacy and Safety of the Association of Nimodipine and Choline Alphoscerate in the Treatment of Cognitive Impairment in Patients with Cerebral Small Vessel Disease. The CONIVaD Trial 138
Functional magnetic resonance imaging with encoding task in patients with mild cognitive impairment and different severity of leukoaraiosis 134
DTI-derived indexes of brain WM correlate with cognitive performance in vascular MCI and small-vessel disease. A TBSS study 132
Letter by Pescini et al Regarding Article, "Peripheral Artery Disease as a Manifestation of Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) and Practical Implications". 132
Post-stroke dementia and cognitive impairment. 131
Relationship between progression of brain white matter changes and late-life depression: 3-year results from the LADIS study. 131
Exploring differences in Cerebral Small Vessel Disease: a comparative analysis of clinical, radiological and cognitive features of Cerebral Amyloid Angiopathy and Deep Perforator Arteriopathy 130
Markers of Inflammation and Hypofibrinolysis Are Associated with Cognitive Dysfunction and Motor Performances in Atrial Fibrillation Patients on Oral Anticoagulant Therapy: Insights from the Strat-AF Study 129
Psychiatric disturbances in CADASIL: a brief review 129
Deep frontal and periventricular age-related white matter changes but not basal ganglia and infratentorial hyperintensities are associated with falls - cross-sectional results from the LADIS study. 129
Factors predicting the Montreal cognitive assessment (MoCA) applicability and performances in a stroke unit. 125
Leukoaraiosis predicts hidden global functioning impairment in nondisabled older people: the LADIS (Leukoaraiosis and Disability in the Elderly) Study. 125
The role of white matter hyperintensities and medial temporal lobe atrophy in age-related executive dysfunctioning. 122
Predictive value of MoCA in the acute phase of stroke on the diagnosis of mid-term cognitive impairment. 122
Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS study. 122
Self-perceived memory complaints predict progression to Alzheimer disease. The LADIS study. 121
White matter changes and late-life depressive symptoms: longitudinal study 120
Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease: a review 120
Neurological abnormalities predict disability: the LADIS (Leukoaraiosis And DISability) study 119
Corpus callosum atrophy as a predictor of age-related cognitive and motor impairment: a 3-year follow-up of the LADIS study cohort. 117
The VAS-COG clinic: an out-patient service for patients with cognitive and behavioral consequences of cerebrovascular diseases. 116
Is type 2 diabetes related to leukoaraiosis? An updated review 116
Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study. 115
Investigations in primary care. 114
Stroke occurrence and leukoaraiosis are independently associated with transition to disability: the LADIS (Leukoaraiosis and disability) Study. 114
Location of lacunar infarcts correlates with cognition in a sample of non-disabled subjects with age-related white-matter changes: the LADIS study. 114
White Matter Lesion Progression in LADIS: Frequency, Clinical Effects, and Sample Size Calculations. 110
Deterioration of gait and balance over time: the effects of age-related white matter change--the LADIS study. 109
Urinary disturbances in elderly non-disabled subjects with cerebral age-related white matter changes. The LADIS (Leukoaraiosis And DISability) Study. 106
Urinary complaints in nondisabled elderly people with age-related white matter changes: the Leukoaraiosis And DISability (LADIS) Study 106
The relation between white-matter lesions and cognition. 105
Depressive symptoms predict cognitive decline and dementia in older people independently of cerebral white matter changes: the LADIS study. 105
Totale 16.200
Categoria #
all - tutte 51.976
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.976


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022621 0 0 65 15 24 46 26 65 30 28 122 200
2022/20231.665 171 357 51 89 119 267 243 82 178 9 81 18
2023/2024656 22 82 115 36 62 61 24 120 22 42 42 28
2024/20254.643 189 567 327 701 1.161 502 88 367 240 123 167 211
2025/20265.614 647 775 439 473 617 185 578 278 333 360 200 729
2026/2027571 202 157 212 0 0 0 0 0 0 0 0 0
Totale 17.520